Advertisement

Topics

Heidelberg Pharma GmbH Company Profile

01:47 EDT 24th June 2018 | BioPortfolio

When working at Boehringer Mannheim (now Roche Diagnostics) from 1987 to 1999, the founders of Heidelberg Pharma, Dr. Dieter Herrmann and Dr. Hans-Georg Opitz, developed technologies and know-how that enable to overcome medical limitations of many well established drugs and pipeline compounds still under development. In connection with a management buy-out, the founders of Heidelberg Pharma took advantage of a provision in German patent law to transfer to Heidelberg Pharma the rights to 14 patent series, including 270 patents and other intellectual property related to their work at Boehringer/Roche. These form the basis of Heidelberg Pharma’s drug research and development activities and are the result of an estimated €20 to €30 million investment (based on the cumulative research and development budget, including clinical trials) by Boehringer Mannheim

Contact

Phone: 49-(0) 6203 1009-13
Fax: 49-(0) 6203 1009-19
Email: info@heidelberg-pharma.com


News Articles [985 Associated News Articles listed on BioPortfolio]

Heidelberg Pharma schließt Lizenzvertrag mit Universität von Texas MD Anderson Cancer Center ab

Bad Marienberg - Die Heidelberg Pharma AG (ISIN DE000A11QVV0/ WKN A11QVV) gab heute den Abschluss eines Lizenzvertrags zwischen ihrer Tochtergesellschaft Heidelberg Pharma Research GmbH und der Uni...

Heidelberg Pharma: Lizenz- und Forschungsdeal mit Magenta Therapeutics

Heidelberg Pharma hat mit Magenta Therapeutics eine Kooperation im Bereich der Wirkstoffforschung vereinbart. "Heidelberg Pharma Research GmbH unterzeichnete die Vereinbarung, bei der aus Magentas ...

Heidelberg Pharma and Magenta Therapeutics Sign Exclusive Multi-Target Research Agreement

Heidelberg Pharma AG and Magenta Therapeutics Inc., a biotechnology company developing therapeutics to improve and extend the use of curative bone marrow transplant for more patients, announced the si...

Heidelberg Pharma: Anfang 2019 wird es spannend - Exklusiv-Interview

Nach zwei Kapitalerhöhungen ist Heidelberg Pharma bis 2020 durchfinanziert. Im Exklusivinterview mit der Redaktion von www.4investors.de erläutert Jan Schmidt-Brand, Vorstandschef von Heidelberg Ph....

DGAP-Gesamtstimmrechtsmitteilung: Heidelberg Pharma AG (deutsch)

Heidelberg Pharma AG: Veröffentlichung der Gesamtzahl der Stimmrechte nach § 41 WpHG mit dem Ziel der europaweiten Verbreitung DGAP Gesamtstimmrechtsmitteilung: Heidelberg Pharma AG / Veröffentlic....

DGAP-News: Heidelberg Pharma schließt Lizenzvertrag mit Universität von Texas MD Anderson Cancer Center ab (deutsch)

Heidelberg Pharma schließt Lizenzvertrag mit Universität von Texas MD Anderson Cancer Center ab DGAP-News: Heidelberg Pharma AG / Schlagwort(e): Kooperation Heidelberg Pharma schließt Lizenzvertra....

Heidelberg Pharma: Kaufempfehlung für die Aktie

Nachdem Heidelberg Pharma gestern Zahlen für das erste Quartal 2018 vorgelegt und die Prognose bestätigt hat, bekräftigen die Analysten bei Baader Helvea Equity Research ihre Kaufempfehlung für di...

Deutscher Biotech-Wert Heidelberg Pharma gewinnt 7,7 Prozent - was ist da los?

Die Aktie von Heidelberg Pharma (frühere Wilex) scheint ihre Konsolidierung der vergangenen Wochen beendet zu haben. Mit einem kräftigen Kurssprung am Montagnachmittag sorgt die Aktie für Aufsehen....

PubMed Articles [49 Associated PubMed Articles listed on BioPortfolio]

Cost-effectiveness analysis of blue light cystoscopy with hexylaminolevulinate in transurethral resection of the bladder.

Photodynamic diagnosis using the optical imaging agent hexaminolevulinate (HAL, Hexvix®, Ipsen Pharma GmbH, Ettlingen, Germany) as an adjunct to white light cystoscopy (WLC) during the initial transu...

Impact of the choice of reference genome on the ability of the core genome SNV methodology to distinguish strains of Salmonella enterica serovar Heidelberg.

Salmonella enterica serovar Heidelberg (S. Heidelberg) is one of the top serovars causing human salmonellosis. The core genome single nucleotide variant pipeline (cgSNV) is one of several whole genome...

Optical Coherence Tomography Angiography of Pigmented Paravenous Retinochoroidal Atrophy.

A 58-year-old man with bilateral pigmented paravenous retinochoroidal atrophy (PPRCA) associated with macular coloboma in the right eye underwent color fundus photography and fundus autofluorescence w...

Moving pharma contracting into the era of accountability.

Correction to: Lonoctocog Alfa: A Review in Haemophilia A.

The article Lonoctocog Alfa: A Review in Haemophilia A, written by Zaina T. Al-Salama and Lesley J. Scott, was originally published Online First without open access. After publication in volume 77...

Clinical Trials [141 Associated Clinical Trials listed on BioPortfolio]

Effects of a PF Ophthalmic Solution Containing HA0.4% and TAU 0.5%

Eligible patients underwent evaluation of ocular surface parameters by Ocular Surface Disease Index (OSDI) and Glaucoma Symptom Scale (GSS) questionnaires, Break Up Time test (BUT), Schirm...

Bioequivalence Study of Linagliptin From Prevaglip 5 mg Tablets(Eva Pharma, Egypt) and Trajenta 5 mg Tablets (Boehringer Ingelheim International GmbH, Germany)

An open label randomized, single dose, two-way crossover bioequivalence study to determine the bioequivalence of Linagliptin from Prevaglip 5 mg tablets(Eva pharma for Pharmaceuticals & Me...

How Well Does the Data Obtained From Heidelberg Edge Perimeter Visual Field Compare to Standard Octopus Visual Field

The purpose of this study is to compare standard automated perimetry (SAP) using the Heidelberg Edge Perimeter (HEP) with the Octopus Visual Field (OVF) analyzer and determine test-retest ...

Measuring Cyclotorsion on Scanning Laser Ophthalmoscopy (SLO)-Fundus Photographs

Pre-Study: Evaluation of the inter- and intrarater reliability of the integrated algorithm by Heidelberg Spectralis for measuring cyclotorsion on SLO-fundus fotographs, and assessment of t...

hsTnT in Patients Admitted to the ED With Atrial Fibrillation in the Era of NOACs - Heidelberg Registry of Atrial Fibrillation

The purpose of the Heidelberg Registry of Atrial Fibrillation (HERA-FIB) is to collect data on the prevalence and clinical significance of elevated cardiac troponin in a large registry of ...

Companies [1262 Associated Companies listed on BioPortfolio]

Heidelberg Pharma GmbH

When working at Boehringer Mannheim (now Roche Diagnostics) from 1987 to 1999, the founders of Heidelberg Pharma, Dr. Dieter Herrmann and Dr. Hans-Georg Opitz, developed technologies and know-how that...

Heidelberg Innovation Fonds Management GmbH

Heidelberg Innovation invests exclusively in Healthcare companies. Focussing on Medical Devices and Specialty Pharma, the firm is recognized as one of the leading venture capital companies specialized...

Technologiepark Heidelberg GmbH

International Science Park with focus on Life Sciences Located close to the University of Heidelberg and to international research institutes [for example: Deutsches Krebsforschungszentrum (DKFZ), E...

Chemie-Kontor GmbH

Chemie-Kontor GmbH trades with chemical specialities for customers in Pharma-, Agro-, Cosmetics and Nutrition Industries and offers a broad range of services. Chemie-Kontor GmbH is agent for: Amberger...

CONCEPT HEIDELBERG GmbH

CONCEPT HEIDELBERG was founded on 1 April 1978. Since then, its services have been focussing on the fields of pharmaceutical industry (incl. API manufacture), cosmetics industry, medical device and bi...

More Information about "Heidelberg Pharma GmbH" on BioPortfolio

We have published hundreds of Heidelberg Pharma GmbH news stories on BioPortfolio along with dozens of Heidelberg Pharma GmbH Clinical Trials and PubMed Articles about Heidelberg Pharma GmbH for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Heidelberg Pharma GmbH Companies in our database. You can also find out about relevant Heidelberg Pharma GmbH Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...


Corporate Database Quicklinks



Searches Linking to this Company Record